Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 82.29M | 81.90M | 76.70M | 71.98M | 70.24M | 67.23M |
Gross Profit | 42.01M | 41.94M | 39.51M | 36.35M | 33.62M | 36.37M |
EBITDA | 5.32M | 13.20M | 14.09M | 9.87M | 12.91M | 14.79M |
Net Income | 8.45M | 7.86M | 7.56M | 4.05M | 7.86M | 9.57M |
Balance Sheet | ||||||
Total Assets | 116.13M | 114.50M | 115.25M | 110.32M | 112.01M | 104.89M |
Cash, Cash Equivalents and Short-Term Investments | 66.48M | 60.47M | 61.86M | 55.74M | 70.26M | 70.64M |
Total Debt | 4.20M | 1.43M | 4.45M | 4.48M | 4.87M | 811.00K |
Total Liabilities | 11.50M | 11.22M | 16.58M | 16.82M | 18.96M | 16.41M |
Stockholders Equity | 104.77M | 103.33M | 98.67M | 93.51M | 93.05M | 88.48M |
Cash Flow | ||||||
Free Cash Flow | 9.28M | 4.91M | 12.60M | -4.12M | 5.62M | 21.41M |
Operating Cash Flow | 10.11M | 6.72M | 12.66M | -3.33M | 6.01M | 21.63M |
Investing Cash Flow | 646.00K | -395.00K | -510.00K | -3.96M | -82.00K | 623.00K |
Financing Cash Flow | -5.67M | -7.42M | -6.40M | -7.58M | -6.36M | -5.55M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | HK$95.20M | 10.08 | 8.84% | 2.10% | -3.17% | 8.16% | |
60 Neutral | HK$15.58B | 5.65 | -7.43% | 4.32% | 11.60% | -21.06% | |
50 Neutral | $8.37B | ― | -9.66% | ― | -44.43% | -281.08% | |
45 Neutral | HK$268.11M | ― | -30.23% | ― | 5.79% | -780.00% | |
44 Neutral | HK$22.55M | 116.47 | 0.88% | ― | 8.34% | ― | |
38 Underperform | HK$36.80M | ― | -9.50% | ― | -58.07% | -303.40% | |
34 Underperform | HK$34.02M | 0.67 | ― | -68.00% | 25.80% |